This is number three of a four part series — maybe five — if I decide to add in either Tesla (for Elon, here) — or Amazon Health. For now, this is what the largest spend of the majors went to in Q1 2026.
You’ll notice that — unlike the others, Pfizer goes into far less detail about exactly what they are jaw-boining about. It is my opinion (expressed here, on and off for about 15 years) that, given how relatively high the company’s spend on lobbying is every year — that this below, barely meets the command of the statute, to describe, in reaonable detail, “a list of the specific issues upon which a lobbyist employed by the registrant engaged in lobbying activities, including, to the maximum extent practicable, a list of bill numbers and references to specific executive branch actions…” at 2 USC § 1604 Section (b)(2)(A):
…[US House] Vaccine Coverage; Pediatric Immunization Schedule; Vaccine Injury Compensation Program; Executive Order 14297 – Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients; H.R. 7837 – Most Favored Patient Act of 2026; Lyme Disease Issues; 340B Issues; Counterfeit Drugs; Inflation Reduction Act (IRA); Prescription Drug User Fee Act (PDUFA); Drug Pricing; PBM Reform; Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage; H.R. 5509 – Safe Step Act; S. 2903 – Safe Step Act; S. 3510 – Biosimilar Inspection Modernization Act of 2025….
[US Senate] Executive Order 14297 – Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients; Prescription Drug User Fee Act (PDUFA); 340B Issues; Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage; PBM Reform; Counterfeit Drugs; P.L. 117-169 – Inflation Reduction Act (IRA) of 2022; Drug Pricing; Medicare/Medicaid Issues….
International Supply Chain; Market Access; Most Favored Nation Policies; Foreign Freeriding Issues; Non-Tariff Trade Barriers; Competiveness Issues; Trade Issues….
Intellectual Property Protections….
Onward, to a warm if cloudy Spring Friday morning — Eli Lilly likely up next, before Noon. Smile… maybe old Elon next, as he takes SpaceX public.
नमस्ते
